in conclusion, the lack of an initial peak and the early decline of muscle g-6-p concentrations suggest that even at physiological concentrations, ffas primarily inhibit glucose transport/phosphorylation, preceding the reduction of whole-body glucose disposal by up to 120 min in humans.